152 related articles for article (PubMed ID: 2142243)
21. [The results of a comparative clinical study of the antiestrogenic preparations toremifene and tamoxifen in locally advanced and disseminated breast cancer].
Konstantinova MM; Gershanovich MA
Vopr Onkol; 1990; 36(10):1182-6. PubMed ID: 2147527
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene.
Valavaara R; Tuominen J; Johansson R
Cancer; 1990 Dec; 66(11):2264-9. PubMed ID: 2147123
[TBL] [Abstract][Full Text] [Related]
23. Introduction to toremifene.
Kangas L
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S3-7. PubMed ID: 2149282
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase II study of toremifene.
Horvath G; Stendahl U; Kalling M; Fernö M; Himmelmann A; Hajba A
Anticancer Res; 1990; 10(2A):323-5. PubMed ID: 2140668
[TBL] [Abstract][Full Text] [Related]
25. Antiestrogen therapy for breast cancer: current strategies and future prospects.
Jordan VC; Tormey DC
Cancer Treat Res; 1988; 39():97-110. PubMed ID: 2908611
[TBL] [Abstract][Full Text] [Related]
26. Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer.
Kohler PC; Hamm JT; Wiebe VJ; DeGregorio MW; Shemano I; Tormey DC
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S19-26. PubMed ID: 2149280
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination].
Chevallier B; Spielmann M; Marty M; Serin D; Pouillart P; Tubiana Hulin M; Mignot L; Pujade Lauraine E; Krams M; Mertens H
Bull Cancer; 1993 Jul; 80(7):624-8. PubMed ID: 8204943
[TBL] [Abstract][Full Text] [Related]
28. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant trials of toremifene vs tamoxifen: the European experience.
Holli K
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):23-7. PubMed ID: 9556787
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
[TBL] [Abstract][Full Text] [Related]
31. [Breast cancer--tamoxifen and tamoxifen analogues for the treatment of breast cancer].
Iino Y; Morishita Y
Nihon Rinsho; 1994 Mar; 52(3):797-803. PubMed ID: 8164385
[TBL] [Abstract][Full Text] [Related]
32. Alternate antiestrogens and approaches to the prevention of breast cancer.
Jordan VC
J Cell Biochem Suppl; 1995; 22():51-7. PubMed ID: 8538210
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of toremifene in carcinoma corporis uteri. Preliminary communication.
Horváth G; Tropé C; Almbo HE
J Steroid Biochem; 1990 Jun; 36(3):241. PubMed ID: 2142245
[TBL] [Abstract][Full Text] [Related]
34. [Antiestrogen therapy in the treatment of breast neoplasms].
Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
[TBL] [Abstract][Full Text] [Related]
35. The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifene.
Valavaara R; Tuominen J; Toivanen A
Cancer Immunol Immunother; 1990; 31(6):381-6. PubMed ID: 2143689
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
Rouanet P; Linares-Cruz G; Dravet F; Poujol S; Gourgou S; Simony-Lafontaine J; Grenier J; Kramar A; Girault J; Le Nestour E; Maudelonde T
J Clin Oncol; 2005 May; 23(13):2980-7. PubMed ID: 15860853
[TBL] [Abstract][Full Text] [Related]
37. A phase I study of toremifene.
Tominaga T; Abe O; Izuo M; Nomura Y
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S27-9. PubMed ID: 2149281
[TBL] [Abstract][Full Text] [Related]
38. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.
Mäenpää JU; Ala-Fossi SL
Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556
[TBL] [Abstract][Full Text] [Related]
39. Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer.
Haarstad H; Gundersen S; Wist E; Raabe N; Mella O; Kvinnsland S
Acta Oncol; 1992; 31(4):425-8. PubMed ID: 1632978
[TBL] [Abstract][Full Text] [Related]
40. Cyclophosphamide, adriamycin, 5-fluorouracil and high-dose toremifene for patients with advanced/recurrent breast cancer. The Japan Toremifene Cooperative Study Group.
Tominaga T; Nomura Y; Uchino J; Hirata K; Kimura M; Yoshida M; Aoyama H; Kinoshita H; Koyama H; Monden Y; Takashima S; Ogawa M
Jpn J Clin Oncol; 1998 Apr; 28(4):250-4. PubMed ID: 9657010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
